Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
Abstract Autoimmunity plays a significant role in the pathogenesis of demyelination. Multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) are now recognised as separate disease entities under the amalgam...
Main Authors: | Joseph A Lopez, Martina Denkova, Sudarshini Ramanathan, Russell C Dale, Fabienne Brilot |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1316 |
Similar Items
-
MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
by: J. Tom Mishael, et al.
Published: (2023-07-01) -
Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System
by: Volkan Taşdemir, et al.
Published: (2018-12-01) -
Double seropositive neuromyelitis optica associated with COVID-19: A case report
by: Dana Antonescu Ghelmez, et al.
Published: (2022-10-01) -
Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01) -
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
by: Helen Cross, et al.
Published: (2021-01-01)